AeruginolactoneCAS# 1005208-88-7 |
Quality Control & MSDS
3D structure
Package In Stock
Number of papers citing our products
| Cas No. | 1005208-88-7 | SDF | Download SDF |
| PubChem ID | 102004678 | Appearance | Powder |
| Formula | C15H20O3 | M.Wt | 248.3 |
| Type of Compound | Sesquiterpenoids | Storage | Desiccate at -20°C |
| Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
| Chemical Name | (5E,9E)-11a-hydroxy-3,6,10-trimethyl-4,7,8,11-tetrahydrocyclodeca[b]furan-2-one | ||
| SMILES | CC1=CCC2=C(C(=O)OC2(CC(=CCC1)C)O)C | ||
| Standard InChIKey | RNKGNLZCXUOTKL-NXAIOARDSA-N | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
| About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
| Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. | ||
| Description | Standard reference |
| In vitro | Characterization of in vivo and in vitro metabolites of furanodiene in rats by high performance liquid chromatography-electrospray ionization mass spectrometry and nuclear magnetic resonance spectra.[Pubmed: 23998967]J Pharm Biomed Anal. 2013 Dec;86:161-8.
|
Aeruginolactone Dilution Calculator
Aeruginolactone Molarity Calculator
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 4.0274 mL | 20.1369 mL | 40.2739 mL | 80.5477 mL | 100.6847 mL |
| 5 mM | 0.8055 mL | 4.0274 mL | 8.0548 mL | 16.1095 mL | 20.1369 mL |
| 10 mM | 0.4027 mL | 2.0137 mL | 4.0274 mL | 8.0548 mL | 10.0685 mL |
| 50 mM | 0.0805 mL | 0.4027 mL | 0.8055 mL | 1.611 mL | 2.0137 mL |
| 100 mM | 0.0403 mL | 0.2014 mL | 0.4027 mL | 0.8055 mL | 1.0068 mL |
| * Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. | |||||
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- TCS 2002
Catalog No.:BCC6074
CAS No.:1005201-24-0
- Blasticidin A
Catalog No.:BCN1830
CAS No.:100513-53-9
- Sterigmatocystin
Catalog No.:BCN6885
CAS No.:10048-13-2
- Gastrin I (human)
Catalog No.:BCC5958
CAS No.:10047-33-3
- Rosiridin
Catalog No.:BCN5970
CAS No.:100462-37-1
- FFN 511
Catalog No.:BCC7799
CAS No.:1004548-96-2
- 1-EBIO
Catalog No.:BCC6904
CAS No.:10045-45-1
- Dihydroresveratrol 3-O-glucoside
Catalog No.:BCN5821
CAS No.:100432-87-9
- Cobicistat (GS-9350)
Catalog No.:BCC2271
CAS No.:1004316-88-4
- Boric acid
Catalog No.:BCC7592
CAS No.:10043-35-3
- Lercanidipine
Catalog No.:BCC5239
CAS No.:100427-26-7
- Danshinspiroketallactone
Catalog No.:BCN3754
CAS No.:100414-80-0
- Gelomulide N
Catalog No.:BCN6641
CAS No.:1005212-02-1
- CVT 10216
Catalog No.:BCC5606
CAS No.:1005334-57-5
- LCL161
Catalog No.:BCC1691
CAS No.:1005342-46-0
- Tirasemtiv
Catalog No.:BCC5183
CAS No.:1005491-05-3
- Monomethylsulochrin
Catalog No.:BCN7255
CAS No.:10056-14-1
- TC ASK 10
Catalog No.:BCC6301
CAS No.:1005775-56-3
- TAK-593
Catalog No.:BCC5142
CAS No.:1005780-62-0
- NF 546
Catalog No.:BCC7804
CAS No.:1006028-37-0
- MK-2894
Catalog No.:BCC1757
CAS No.:1006036-87-8
- MK-2894 sodium salt
Catalog No.:BCC1758
CAS No.:1006036-88-9
- (-)-Epipinoresinol
Catalog No.:BCN3377
CAS No.:10061-38-8
- Desloratadine
Catalog No.:BCC4540
CAS No.:100643-71-8
Characterization of in vivo and in vitro metabolites of furanodiene in rats by high performance liquid chromatography-electrospray ionization mass spectrometry and nuclear magnetic resonance spectra.[Pubmed:23998967]
J Pharm Biomed Anal. 2013 Dec;86:161-8.
Furanodiene is an active ingredient of Rhizoma Curcumae, a very famous Traditional Chinese Medicine (TCM) widely used for the treatment of cancer. Although the anti-tumor effect of furanodiene has well been established, its metabolic profile in vivo and in vitro is still unclear. In the present study, the metabolites of furanodiene in rats were studied. After oral administration of furanodiene, the rats' urine, feces and bile were collected and produced seven metabolites by the use of macroporous adsorption resin chromatography, and semi-preparative high performance liquid chromatography. Their structures were identified by mass spectrometry and NMR data including (1)H, (13)C, and two-dimensional NMR data. All of these metabolites were phase I metabolites, with three new compounds including 2beta-hydroxyl-Aeruginolactone (2), 14-hydroxyl-Aeruginolactone (3), 1beta,8beta-dihydroxyeudesm-4,7(11)-dien-8alpha,12-olide (4a), and four known compounds, 1beta,10alpha,4alpha,5beta-diepoxy-8alpha-hydroxy-glechoman-8alpha,12-olide (1), 1beta,8beta-dihydroxyeudesm-4(14),7(11)-dien-8alpha,12-olide (4b), 1beta,8beta-dihydroxyeudesm-3,7(11)-dien-8alpha,12-olide (5) and Aeruginolactone (6). Interestingly, the metabolite 6 was found to be a primary metabolite in urine, bile and feces. All metabolites were found to be both in urine and bile but only few metabolites except the metabolite 6 presented in feces after oral dose of furanodiene to rats. Furthermore, the metabolic pathways of furanodiene were proposed using an in vitro assay by incubation of furanodiene and its metabolites in vivo with rat liver S9 or liver microsomes. Clearly, Aeruginolactone (6) seemed to be a major precursor for other metabolites.
